MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma
Summary Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this stud...
Saved in:
Published in | Current medical science Vol. 38; no. 2; pp. 245 - 251 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Wuhan
Huazhong University of Science and Technology
01.04.2018
Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells
in vivo
could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis. |
---|---|
AbstractList | Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis. Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis. Summary Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis. |
Author | Liu, Jing Zhang, Ya-fei Wang, La-mei Zhao, Meng-ya Huang, Xing |
AuthorAffiliation | Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China |
AuthorAffiliation_xml | – name: Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China |
Author_xml | – sequence: 1 givenname: Meng-ya surname: Zhao fullname: Zhao, Meng-ya organization: Tongji Medical College, Huazhong University of Science and Technology – sequence: 2 givenname: La-mei surname: Wang fullname: Wang, La-mei organization: Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine – sequence: 3 givenname: Jing surname: Liu fullname: Liu, Jing organization: Department of Emergency Medicine, Zhongnan Hospital of Wuhan University – sequence: 4 givenname: Xing surname: Huang fullname: Huang, Xing organization: Department of Gastroenterology, Zhongnan Hospital of Wuhan University – sequence: 5 givenname: Jing surname: Liu fullname: Liu, Jing organization: Department of Gastroenterology, Zhongnan Hospital of Wuhan University – sequence: 6 givenname: Ya-fei surname: Zhang fullname: Zhang, Ya-fei email: zhangyafei1127@163.com organization: Department of Gastroenterology, Zhongnan Hospital of Wuhan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30074182$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9v1DAQxS1UREvpB-CCfERCgbGdP85xtV0oUoEKFokLshxnNus2sVM7Ee23x6u0QkKCk8fy743nzXtOjpx3SMhLBm8ZQPUuMlbUZQZMZkxWPKuekBNecJHJuv5xlGpIr-kOx-QsRtuAYLwUTPJn5FikBnkqT8jPT_Zrxhn9No9jwBgx0pXz9sZGOu2Dn7s93erQ4WRdR6_O1-c51a6lV9vNZ2odvZgH7egm-nGvO9Q9XbXovNHBWOcH_YI83ek-4tnDeUq-v99s1xfZ5ZcPH9ery8wICVPWMGiThdJwwFxwjbWQRdkUtSlka0xT4g54JYVpDhZqWdWC5cC0rhHKvGnEKXmz9P2l3U67Tl37Obj0o5qu72_au7tGIU-bAp6MJ_r1Qo_B384YJzXYaLDvtUM_R8VBigqkBJHQVw_o3AzYqjHYQYd79bjABFQLYIKPMeBOGTvpyXo3BW17xUAd0lJLWirNoA5pqcMU7C_lY_P_afiiiYl1HYY_Rv8t-g1apKO1 |
CitedBy_id | crossref_primary_10_1007_s11010_022_04384_6 crossref_primary_10_3389_fonc_2019_00919 crossref_primary_10_1186_s12935_019_0728_y crossref_primary_10_3892_ijo_2020_4992 crossref_primary_10_3390_ijms22020627 crossref_primary_10_3892_mmr_2019_10138 crossref_primary_10_3389_fonc_2021_702258 crossref_primary_10_3390_nano11123458 crossref_primary_10_3390_pharmaceutics15082061 crossref_primary_10_3390_jcm10010117 crossref_primary_10_1016_j_fct_2018_10_059 crossref_primary_10_1007_s40520_024_02711_z crossref_primary_10_1016_j_lfs_2021_119926 crossref_primary_10_3892_ijmm_2019_4258 crossref_primary_10_1016_j_tice_2022_101771 crossref_primary_10_1080_15592294_2021_1916697 crossref_primary_10_1080_14737159_2019_1563485 crossref_primary_10_1016_j_cca_2025_120242 crossref_primary_10_1016_j_drup_2024_101099 crossref_primary_10_3390_cancers12010056 crossref_primary_10_1002_ar_24362 crossref_primary_10_1007_s11596_022_2536_1 crossref_primary_10_1016_j_heliyon_2024_e36989 |
Cites_doi | 10.1016/j.bbamcr.2013.06.026 10.1002/ddr.21257 10.1155/2015/716816 10.1016/S1470-2045(12)70073-6 10.1016/j.abb.2015.07.001 10.1158/1078-0432.CCR-12-1959 10.1016/j.canlet.2012.01.003 10.1016/j.jtcvs.2007.08.055 10.1038/mt.2013.35 10.1038/nature08268 10.4161/cbt.10.12.14252 10.1007/s13277-014-1623-8 10.1007/s11596-014-1257-5 10.1124/mi.10.2.5 10.1371/journal.pone.0156772 10.1038/nrg3074 10.1186/1471-2407-14-819 10.1006/meth.2001.1262 10.1159/000454696 10.1038/nrc3767 10.1177/1010428317705754 10.1177/1010428317707372 10.1002/ar.22769 10.3109/0284186X.2015.1064161 10.1590/1414-431X20143906 10.1371/journal.pone.0103373 10.1186/bcr2803 10.18632/oncotarget.4814 10.1155/2013/756134 |
ContentType | Journal Article |
Copyright | Huazhong University of Science and Technology 2018 Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Huazhong University of Science and Technology 2018 – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | AAYXX CITATION NPM 7X8 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1007/s11596-018-1872-7 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2523-899X |
EndPage | 251 |
ExternalDocumentID | tjykdxxb_e201802007 30074182 10_1007_s11596_018_1872_7 |
Genre | Journal Article |
GrantInformation_xml | – fundername: grants from the National Natural Science Foundation of China funderid: (81470818,81472735 and 81472033) |
GroupedDBID | -05 -0E -EM -SE -S~ .VR 0R~ 2J2 2JN 2JY 2KG 2LR 30V 406 408 5VR 92M 95- 96X 9D9 9DE AAAVM AACDK AAHNG AAIAL AAJBT AANZL AASML AATNV AAUYE AAXDM AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABJNI ABKCH ABKZE ABMQK ABNWP ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACHSB ACMDZ ACMLO ACOKC ACZOJ ADKNI ADRFC ADTPH ADURQ ADYFF AEFQL AEJRE AEMSY AESKC AEVLU AEXYK AFBBN AFLOW AFQWF AFUIB AGDGC AGJBK AGMZJ AGQEE AGRTI AHSBF AIAKS AIGIU AILAN AITGF AJRNO ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR AOCGG AXYYD B-. BA0 BDATZ BGNMA CAJEE CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD FERAY FFXSO FIGPU FINBP FNLPD FSGXE G-Y G-Z GGCAI GNWQR GQ7 GRRUI IKXTQ IWAJR IXD I~Z J-C JZLTJ KOV LLZTM M4Y MA- NPVJJ NQJWS NU0 O9J PF0 PT4 Q-- QOR QOS RHV ROL RSV RT5 S16 S37 S3B SAP SCLPG SDE SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SRMVM SSLCW STPWE SZN T8U TCJ TGQ TSG TUC U1F U1G U2A U5E U5O UOJIU UTJUX UZXMN VC2 VFIZW YLTOR Z87 ZMTXR ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NPM 7X8 ABRTQ -Y2 .86 06C 06D 0VY 1N0 29K 29~ 2B. 2KM 2~H 4.4 40D 40E 4A8 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 93N 95. 95~ AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABJOX ABMNI ABQBU ABQSL ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADHKG ADKPE ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AFWTZ AFZKB AGAYW AGQMX AGQPQ AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW ALWAN ARMRJ AZFZN CAG CCEZO CHBEP CIEJG COF CS3 CW9 D-I ESBYG FA0 FEDTE FRRFC FWDCC GGRSB GJIRD H13 HF~ HMJXF HRMNR HVGLF HZ~ IJ- I~X JBSCW JUIAU N2Q NDZJH O9- O93 O9I P9S PSX R-E R89 R9I RIG RPX S.. S1Z S27 SCL SMD SPISZ SZ9 T13 TT1 U9L UG4 W48 WK8 ZOVNA |
ID | FETCH-LOGICAL-c380t-b10d8726c20e432ae93856b59c58dccb6ef02783cb1263987931401aa9e064bb3 |
IEDL.DBID | U2A |
ISSN | 2096-5230 2523-899X 1672-0733 |
IngestDate | Thu May 29 04:06:48 EDT 2025 Fri Jul 11 10:54:20 EDT 2025 Wed Feb 19 02:42:16 EST 2025 Thu Jul 10 07:35:44 EDT 2025 Thu Apr 24 23:04:10 EDT 2025 Fri Feb 21 02:37:17 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | PDCD4 PTEN miR-21 esophageal adenocarcinoma anoikis resistance |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c380t-b10d8726c20e432ae93856b59c58dccb6ef02783cb1263987931401aa9e064bb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 30074182 |
PQID | 2083708803 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | wanfang_journals_tjykdxxb_e201802007 proquest_miscellaneous_2083708803 pubmed_primary_30074182 crossref_citationtrail_10_1007_s11596_018_1872_7 crossref_primary_10_1007_s11596_018_1872_7 springer_journals_10_1007_s11596_018_1872_7 |
PublicationCentury | 2000 |
PublicationDate | 2018-04-01 |
PublicationDateYYYYMMDD | 2018-04-01 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Wuhan |
PublicationPlace_xml | – name: Wuhan – name: China |
PublicationTitle | Current medical science |
PublicationTitleAbbrev | CURR MED SCI |
PublicationTitleAlternate | Curr Med Sci |
PublicationTitle_FL | Journal of Huazhong University of Science and Technology(Medical Science) |
PublicationYear | 2018 |
Publisher | Huazhong University of Science and Technology Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China |
Publisher_xml | – name: Huazhong University of Science and Technology – name: Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China |
References | Young, Santhanam, Yoshikawa (CR23) 2010; 10 Paoli, Giannoni, Chiarugi (CR1) 2013; 1833 Pfeffer, Yang, Pfeffer (CR10) 2015; 76 Gaudelot, Gibier, Pottier (CR29) 2017; 39 Zhu, Xu (CR13) 2014; 9 He, Dong, Zhai (CR30) 2015; 6 Wu, Yang, Xiang (CR18) 2014; 34 Yang, Zheng, Yan (CR3) 2013; 296 Khalid, Hussain, Manzoor (CR26) 2017; 39 Sicard, Gayral, Lulka (CR32) 2013; 21 Schafer, Grassian, Song (CR15) 2009; 461 Kong, Ferland-McCollough, Jackson (CR7) 2012; 13 Yan, Wu, Zhang (CR31) 2011; 13 Liu, Zhu, Yang (CR9) 2014; 35 Yu, Hu, Kuang (CR17) 2013; 19 Gross, Kropp, Khatib (CR8) 2017; 6 Winther, Alsner, Tramm (CR21) 2015; 54 Markou, Zavridou, Lianidou (CR11) 2016; 7 Kumar, Rajendran, Sethumadhavan (CR27) 2013; 2013 Chen, Xu, Chen (CR28) 2015; 3 Slattum, Rosenblatt (CR5) 2014; 14 Malagobadan, Nagoor (CR2) 2015; 2015 Wang, Wang, Tang (CR24) 2015; 580 Meng, Lu, Mei (CR20) 2014; 47 Esteller (CR6) 2011; 12 Feber, Xi, Luketich (CR19) 2008; 135 Wang, Li, Zhu (CR14) 2014; 14 Zhao, Schnitzler, Iyer (CR12) 2016; 11 Pan, Wang, Wang (CR22) 2010; 10 Ming, He (CR25) 2012; 319 Livak, Schmittgen (CR16) 2001; 25 Pachmayr, Treese, Stein (CR4) 2017; 33 W Zhu (1872_CR13) 2014; 9 G Wang (1872_CR24) 2015; 580 M Esteller (1872_CR6) 2011; 12 W Wang (1872_CR14) 2014; 14 S Malagobadan (1872_CR2) 2015; 2015 J Liu (1872_CR9) 2014; 35 J Yang (1872_CR3) 2013; 296 LX Yan (1872_CR31) 2011; 13 X Pan (1872_CR22) 2010; 10 SR Pfeffer (1872_CR10) 2015; 76 A Khalid (1872_CR26) 2017; 39 F Sicard (1872_CR32) 2013; 21 KJ Livak (1872_CR16) 2001; 25 C He (1872_CR30) 2015; 6 J Zhao (1872_CR12) 2016; 11 A Kumar (1872_CR27) 2013; 2013 MR Young (1872_CR23) 2010; 10 E Pachmayr (1872_CR4) 2017; 33 P Paoli (1872_CR1) 2013; 1833 J Chen (1872_CR28) 2015; 3 MF Wu (1872_CR18) 2014; 34 N Gross (1872_CR8) 2017; 6 A Markou (1872_CR11) 2016; 7 YW Kong (1872_CR7) 2012; 13 XR Meng (1872_CR20) 2014; 47 K Gaudelot (1872_CR29) 2017; 39 GM Slattum (1872_CR5) 2014; 14 ZT Schafer (1872_CR15) 2009; 461 A Feber (1872_CR19) 2008; 135 M Winther (1872_CR21) 2015; 54 M Ming (1872_CR25) 2012; 319 SJ Yu (1872_CR17) 2013; 19 28210157 - Lung Cancer (Auckl). 2016 Mar 02;7:19-27 24943812 - Nat Rev Cancer. 2014 Jul;14(7):495-501 19693011 - Nature. 2009 Sep 3;461(7260):109-13 28906477 - Biology (Basel). 2017 Sep 14;6(3):null 22652233 - Lancet Oncol. 2012 Jun;13(6):e249-58 11846609 - Methods. 2001 Dec;25(4):402-8 24327805 - ScientificWorldJournal. 2013 Nov 13;2013:756134 22094949 - Nat Rev Genet. 2011 Nov 18;12(12):861-74 28714373 - Tumour Biol. 2017 Jul;39(7):1010428317707372 28785563 - Visc Med. 2017 Mar;33(1):11-20 18242245 - J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260 26587543 - Biomed Res Int. 2015;2015:716816 28621226 - Tumour Biol. 2017 Jun;39(6):1010428317705754 25098614 - Braz J Med Biol Res. 2014 Sep;47(9):811-7 22266095 - Cancer Lett. 2012 Jun 28;319(2):125-129 20368367 - Mol Interv. 2010 Apr;10(2):76-9 26734640 - Ann Transl Med. 2015 Dec;3(21):330 24710931 - J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):190-194 23340296 - Clin Cancer Res. 2013 Mar 15;19(6):1389-99 23830918 - Biochim Biophys Acta. 2013 Dec;1833(12):3481-3498 24446181 - Tumour Biol. 2014 May;35(5):3975-9 26481465 - Acta Oncol. 2015;54(9):1582-91 25376700 - BMC Cancer. 2014 Nov 07;14:819 27276022 - PLoS One. 2016 Jun 08;11(6):e0156772 23481326 - Mol Ther. 2013 May;21(5):986-94 26311740 - Oncotarget. 2015 Oct 6;6(30):28867-81 21219636 - Breast Cancer Res. 2011 Jan 10;13(1):R2 21139417 - Cancer Biol Ther. 2010 Dec 15;10(12):1224-32 25098165 - PLoS One. 2014 Aug 06;9(8):e103373 26082192 - Drug Dev Res. 2015 Sep;76(6):270-7 26142886 - Arch Biochem Biophys. 2015 Aug 15;580:64-74 23963853 - Anat Rec (Hoboken). 2013 Oct;296(10):1501-8 |
References_xml | – volume: 1833 start-page: 3481 issue: 12 year: 2013 end-page: 3498 ident: CR1 article-title: Anoikis molecular pathways and its role in cancer progression publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2013.06.026 – volume: 76 start-page: 270 issue: 6 year: 2015 end-page: 277 ident: CR10 article-title: The Role of miR-21 in Cancer publication-title: Drug Dev Res doi: 10.1002/ddr.21257 – volume: 6 start-page: 28867 issue: 30 year: 2015 end-page: 28881 ident: CR30 article-title: MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway publication-title: Oncotarget – volume: 2015 start-page: 716816 year: 2015 ident: CR2 article-title: Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential publication-title: Biomed Res Int doi: 10.1155/2015/716816 – volume: 13 start-page: e249 issue: 6 year: 2012 end-page: 258 ident: CR7 article-title: microRNAs in cancer management publication-title: Lancet Oncol doi: 10.1016/S1470-2045(12)70073-6 – volume: 580 start-page: 64 year: 2015 end-page: 74 ident: CR24 article-title: Targeting strategies on miRNA-21 and PDCD4 for glioblastoma publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2015.07.001 – volume: 19 start-page: 1389 issue: 6 year: 2013 end-page: 1399 ident: CR17 article-title: MircroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-1959 – volume: 2013 start-page: 756134 year: 2013 ident: CR27 article-title: AKT kinase pathway: a leading target in cancer research publication-title: Sci World J – volume: 319 start-page: 125 issue: 2 year: 2012 end-page: 129 ident: CR25 article-title: PTEN in DNA damage repair publication-title: Cancer Lett doi: 10.1016/j.canlet.2012.01.003 – volume: 135 start-page: 255 issue: 2 year: 2008 end-page: 260 ident: CR19 article-title: MicroRNA expression profiles of esophageal cancer publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2007.08.055 – volume: 21 start-page: 986 issue: 5 year: 2013 end-page: 994 ident: CR32 article-title: Targeting miR-21 for the therapy of pancreatic cancer publication-title: Mol Ther doi: 10.1038/mt.2013.35 – volume: 461 start-page: 109 issue: 7260 year: 2009 end-page: 113 ident: CR15 article-title: Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment publication-title: Nature doi: 10.1038/nature08268 – volume: 10 start-page: 1224 issue: 12 year: 2010 end-page: 1232 ident: CR22 article-title: MicroRNA-21: a novel therapeutic target in human cancer publication-title: Cancer Biol Ther doi: 10.4161/cbt.10.12.14252 – volume: 35 start-page: 3975 issue: 5 year: 2014 end-page: 3979 ident: CR9 article-title: MicroRNA-21 is a novel promising target in cancer radiation therapy publication-title: Tumour Biol doi: 10.1007/s13277-014-1623-8 – volume: 34 start-page: 190 issue: 2 year: 2014 end-page: 194 ident: CR18 article-title: miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7 publication-title: J Huazhong Univ Sci Technolog Med Sci doi: 10.1007/s11596-014-1257-5 – volume: 7 start-page: 19 year: 2016 end-page: 27 ident: CR11 article-title: miRNA-21 as a novel therapeutic target in lung cancer publication-title: Lung Cancer (Auckl) – volume: 10 start-page: 76 issue: 2 year: 2010 end-page: 79 ident: CR23 article-title: Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue publication-title: Mol Interv doi: 10.1124/mi.10.2.5 – volume: 11 start-page: e0156772 issue: 6 year: 2016 ident: CR12 article-title: MicroRNAOffset RNA Alters Gene Expression and Cell Proliferation publication-title: PLoS One doi: 10.1371/journal.pone.0156772 – volume: 12 start-page: 861 issue: 12 year: 2011 end-page: 874 ident: CR6 article-title: Non-coding RNAs in human disease publication-title: Nat Rev Genet doi: 10.1038/nrg3074 – volume: 14 start-page: 819 year: 2014 ident: CR14 article-title: MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis publication-title: BMC Cancer doi: 10.1186/1471-2407-14-819 – volume: 25 start-page: 402 issue: 4 year: 2001 end-page: 408 ident: CR16 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 33 start-page: 11 issue: 1 year: 2017 end-page: 20 ident: CR4 article-title: Underlying Mechanisms for Distant Metastasis—Molecular Biology publication-title: Visc Med doi: 10.1159/000454696 – volume: 6 start-page: 34 issue: 3 year: 2017 ident: CR8 article-title: MicroRNA Signaling in Embryo Development publication-title: Biology (Basel) – volume: 14 start-page: 495 issue: 7 year: 2014 end-page: 501 ident: CR5 article-title: Tumour cell invasion: an emerging role for basal epithelial cell extrusion publication-title: Nat Rev Cancer doi: 10.1038/nrc3767 – volume: 39 start-page: 1010428317705754 issue: 6 year: 2017 ident: CR26 article-title: PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma publication-title: Tumour Biol doi: 10.1177/1010428317705754 – volume: 3 start-page: 330 issue: 21 year: 2015 ident: CR28 article-title: The critical roles of miR-21 in anti-cancer effects of curcumin publication-title: Ann Transl Med – volume: 39 start-page: 1010428317707372 issue: 7 year: 2017 ident: CR29 article-title: Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma publication-title: Tumour Biol doi: 10.1177/1010428317707372 – volume: 296 start-page: 1501 issue: 10 year: 2013 end-page: 1508 ident: CR3 article-title: Integration of autophagy and anoikis resistance in solid tumors publication-title: Anat Rec (Hoboken) doi: 10.1002/ar.22769 – volume: 54 start-page: 1582 issue: 9 year: 2015 end-page: 1591 ident: CR21 article-title: Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer publication-title: Acta Oncol doi: 10.3109/0284186X.2015.1064161 – volume: 47 start-page: 811 issue: 9 year: 2014 end-page: 817 ident: CR20 article-title: Expression analysis of miRNA and target mRNAs in esophageal cancer publication-title: Braz J Med Biol Res doi: 10.1590/1414-431X20143906 – volume: 9 start-page: e103373 issue: 8 year: 2014 ident: CR13 article-title: MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0103373 – volume: 13 start-page: R2 issue: 1 year: 2011 ident: CR31 article-title: Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, migration and tumor growth publication-title: Breast Cancer Res doi: 10.1186/bcr2803 – volume: 3 start-page: 330 issue: 21 year: 2015 ident: 1872_CR28 publication-title: Ann Transl Med – volume: 13 start-page: R2 issue: 1 year: 2011 ident: 1872_CR31 publication-title: Breast Cancer Res doi: 10.1186/bcr2803 – volume: 14 start-page: 495 issue: 7 year: 2014 ident: 1872_CR5 publication-title: Nat Rev Cancer doi: 10.1038/nrc3767 – volume: 13 start-page: e249 issue: 6 year: 2012 ident: 1872_CR7 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(12)70073-6 – volume: 135 start-page: 255 issue: 2 year: 2008 ident: 1872_CR19 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2007.08.055 – volume: 1833 start-page: 3481 issue: 12 year: 2013 ident: 1872_CR1 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2013.06.026 – volume: 296 start-page: 1501 issue: 10 year: 2013 ident: 1872_CR3 publication-title: Anat Rec (Hoboken) doi: 10.1002/ar.22769 – volume: 12 start-page: 861 issue: 12 year: 2011 ident: 1872_CR6 publication-title: Nat Rev Genet doi: 10.1038/nrg3074 – volume: 6 start-page: 34 issue: 3 year: 2017 ident: 1872_CR8 publication-title: Biology (Basel) – volume: 19 start-page: 1389 issue: 6 year: 2013 ident: 1872_CR17 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-1959 – volume: 6 start-page: 28867 issue: 30 year: 2015 ident: 1872_CR30 publication-title: Oncotarget doi: 10.18632/oncotarget.4814 – volume: 2015 start-page: 716816 year: 2015 ident: 1872_CR2 publication-title: Biomed Res Int doi: 10.1155/2015/716816 – volume: 10 start-page: 76 issue: 2 year: 2010 ident: 1872_CR23 publication-title: Mol Interv doi: 10.1124/mi.10.2.5 – volume: 7 start-page: 19 year: 2016 ident: 1872_CR11 publication-title: Lung Cancer (Auckl) – volume: 25 start-page: 402 issue: 4 year: 2001 ident: 1872_CR16 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 39 start-page: 101042831770737 issue: 7 year: 2017 ident: 1872_CR29 publication-title: Tumour Biol doi: 10.1177/1010428317707372 – volume: 33 start-page: 11 issue: 1 year: 2017 ident: 1872_CR4 publication-title: Visc Med doi: 10.1159/000454696 – volume: 76 start-page: 270 issue: 6 year: 2015 ident: 1872_CR10 publication-title: Drug Dev Res doi: 10.1002/ddr.21257 – volume: 10 start-page: 1224 issue: 12 year: 2010 ident: 1872_CR22 publication-title: Cancer Biol Ther doi: 10.4161/cbt.10.12.14252 – volume: 54 start-page: 1582 issue: 9 year: 2015 ident: 1872_CR21 publication-title: Acta Oncol doi: 10.3109/0284186X.2015.1064161 – volume: 14 start-page: 819 year: 2014 ident: 1872_CR14 publication-title: BMC Cancer doi: 10.1186/1471-2407-14-819 – volume: 580 start-page: 64 year: 2015 ident: 1872_CR24 publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2015.07.001 – volume: 35 start-page: 3975 issue: 5 year: 2014 ident: 1872_CR9 publication-title: Tumour Biol doi: 10.1007/s13277-014-1623-8 – volume: 39 start-page: 101042831770575 issue: 6 year: 2017 ident: 1872_CR26 publication-title: Tumour Biol doi: 10.1177/1010428317705754 – volume: 11 start-page: e0156772 issue: 6 year: 2016 ident: 1872_CR12 publication-title: PLoS One doi: 10.1371/journal.pone.0156772 – volume: 319 start-page: 125 issue: 2 year: 2012 ident: 1872_CR25 publication-title: Cancer Lett doi: 10.1016/j.canlet.2012.01.003 – volume: 461 start-page: 109 issue: 7260 year: 2009 ident: 1872_CR15 publication-title: Nature doi: 10.1038/nature08268 – volume: 9 start-page: e103373 issue: 8 year: 2014 ident: 1872_CR13 publication-title: PLoS One doi: 10.1371/journal.pone.0103373 – volume: 34 start-page: 190 issue: 2 year: 2014 ident: 1872_CR18 publication-title: J Huazhong Univ Sci Technolog Med Sci doi: 10.1007/s11596-014-1257-5 – volume: 2013 start-page: 756134 year: 2013 ident: 1872_CR27 publication-title: Sci World J doi: 10.1155/2013/756134 – volume: 47 start-page: 811 issue: 9 year: 2014 ident: 1872_CR20 publication-title: Braz J Med Biol Res doi: 10.1590/1414-431X20143906 – volume: 21 start-page: 986 issue: 5 year: 2013 ident: 1872_CR32 publication-title: Mol Ther doi: 10.1038/mt.2013.35 – reference: 22094949 - Nat Rev Genet. 2011 Nov 18;12(12):861-74 – reference: 26082192 - Drug Dev Res. 2015 Sep;76(6):270-7 – reference: 22266095 - Cancer Lett. 2012 Jun 28;319(2):125-129 – reference: 25376700 - BMC Cancer. 2014 Nov 07;14:819 – reference: 20368367 - Mol Interv. 2010 Apr;10(2):76-9 – reference: 23963853 - Anat Rec (Hoboken). 2013 Oct;296(10):1501-8 – reference: 23830918 - Biochim Biophys Acta. 2013 Dec;1833(12):3481-3498 – reference: 28906477 - Biology (Basel). 2017 Sep 14;6(3):null – reference: 24710931 - J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):190-194 – reference: 26311740 - Oncotarget. 2015 Oct 6;6(30):28867-81 – reference: 24943812 - Nat Rev Cancer. 2014 Jul;14(7):495-501 – reference: 11846609 - Methods. 2001 Dec;25(4):402-8 – reference: 24327805 - ScientificWorldJournal. 2013 Nov 13;2013:756134 – reference: 23340296 - Clin Cancer Res. 2013 Mar 15;19(6):1389-99 – reference: 26142886 - Arch Biochem Biophys. 2015 Aug 15;580:64-74 – reference: 19693011 - Nature. 2009 Sep 3;461(7260):109-13 – reference: 25098614 - Braz J Med Biol Res. 2014 Sep;47(9):811-7 – reference: 28785563 - Visc Med. 2017 Mar;33(1):11-20 – reference: 21139417 - Cancer Biol Ther. 2010 Dec 15;10(12):1224-32 – reference: 28210157 - Lung Cancer (Auckl). 2016 Mar 02;7:19-27 – reference: 26587543 - Biomed Res Int. 2015;2015:716816 – reference: 22652233 - Lancet Oncol. 2012 Jun;13(6):e249-58 – reference: 18242245 - J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260 – reference: 26481465 - Acta Oncol. 2015;54(9):1582-91 – reference: 27276022 - PLoS One. 2016 Jun 08;11(6):e0156772 – reference: 25098165 - PLoS One. 2014 Aug 06;9(8):e103373 – reference: 28621226 - Tumour Biol. 2017 Jun;39(6):1010428317705754 – reference: 23481326 - Mol Ther. 2013 May;21(5):986-94 – reference: 24446181 - Tumour Biol. 2014 May;35(5):3975-9 – reference: 26734640 - Ann Transl Med. 2015 Dec;3(21):330 – reference: 28714373 - Tumour Biol. 2017 Jul;39(7):1010428317707372 – reference: 21219636 - Breast Cancer Res. 2011 Jan 10;13(1):R2 |
SSID | ssib031263182 ssj0002039635 ssib051367596 ssib034325102 ssj0057624 |
Score | 2.2555027 |
Snippet | Summary
Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis... Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a... Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix.It has been determined that acquisition of resistance to anoikis is a... |
SourceID | wanfang proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 245 |
SubjectTerms | Medicine Medicine & Public Health |
Title | MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma |
URI | https://link.springer.com/article/10.1007/s11596-018-1872-7 https://www.ncbi.nlm.nih.gov/pubmed/30074182 https://www.proquest.com/docview/2083708803 https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201802007 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rS8MwEA8-QPwivp0vIuyTUuiSpms_Dp2IMBHZYF8kJG0qm5rJuoH-99616TZRBn7Pg17u2bv7HSF17mvdjEQGkhYoL4iyphdrhSiiiQoQKFYp7B3uPIR3veC-L_qujzuvqt2rlGShqefNbmB5MfqFg6ImuIWrZF1A6I51XD3WqpiIN1gIfDqz2dg4KRYwsgRilAmHMTcsM3HAhFjqyMCdx8Bslv3869af9uuXU7qQUC3agGym7MuCxbrdJlvO1aStkjd2yIqxu2Sj45Lpe-S5M3jyWIPiYM8CQjynLTsagEdJ3fQe2i3qxOEe-nhzfRNQZVP62G0_0IGlxe9_2sYxCKCT8CJQYWAZx3D66F3tk95tu3t957lpC17CI3_i6YafwheGCfMN0EyZmEci1CJORJQmiQ5NhllKnmikcByBYGNwplRswK3Rmh-QNTuy5ohQ0AFpBkaPcwXRXUOo0KSpYjoF5wt7b2vEr2goEwdFjhMx3uQcRBnJLoHsEskuYcvlbMtHicOxbPFF9TASpAVTIMqa0TSXzEewH9BZvEYOyxebHccL9ypiNXJVPaF0Ap0vu6vuXnm-eDL8ek0_P7U0DPHR8Hfw8b8OPSGbuLOsEDola5Px1JyB8zPR5wWzfwP-__Dr |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBddBm1fxj7aNfvoNMhTi8GRLEd-DPkg7ZpQRgJ5KUKy5ZFuVUqTQvrf986Wk4yOwN6lEz6d7n7y6X5HSIOHxrSkyOGkRTqIZN4KEqORRTTVERLFao21w8NRPJhEl1Mx9XXci-q1e5WSLDz1ptgNIi_efkGQbAEsfEVeAxaQaMoT1q6MiDdZDHa6jtlYOCm2OLIEcpQJzzF3W2biwAjxqSMDOI8Xs3X281-r_h2_XoDSrYRqUQbkcu1-bUWs_lvyxkNN2i5t4x3Zs-492R_6ZPoHcjOc_QxYk2Jjz4JCfEHbbj4DREl99x46Lt6Jwzr0utvpRlS7jF6PeyM6c7T4_U972AYBfBIuBC4MIuMDSJ_f6SMy6ffGnUHguy0EKZfhMjDNMIMvjFMWWtCZtgmXIjYiSYXM0tTENscsJU8NajiRcLDxcqZ1YgHWGMOPSc3NnT0hFHxAlkPQ41zD7a4pdGyzTDOTAfjC2ts6CSsdqtRTkWNHjD9qQ6KMalegdoVqVzDlbD3lvuTh2DX4e7UxCk4LpkC0s_PHhWIhkv2Az-J18rHcsbU4XsAryerkvNpC5Q_0YtdaDb_Lm8HL26ff2WpllGXIj4a_gz_9l9Bv5GAwHl6pq4vRj8_kEKWUr4W-kNry4dF-BSC0NKeF4T8Dh4Hz3g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1RT9swELYGkxAvE7AB3QYYiaehiNSO0-Sxoq1go1U1tRIvyLJjBxWYi2iQ4N_vLnHaIhAS7_ZZOZ99n3N33xFyxEOtW4nI4aRFKoiSvBWkWiGLaKYiJIpVCmuH-4P4bBz9vhSXvs_prM52r0OSVU0DsjS54uTe5CeLwjfwwvgSBqFJCyDiCvkcYTEwGPSYtWuD4k0Wg83O_TcWUYolviyBfGXC883dVFE5MEhMe2QA7fGRNo-EvrXqS1_2CqAuBVfLkiCXK3e95L16G-SLh520XdnJJvlk3RZZ6_vA-ldy1Z_8DViTYpPPkk58RttuOgF0SX0nHzoqc8ZhHTrsnHYiqpyhw1F3QCeOlqEA2sWWCHA_4UJwnYGXfADp03_qGxn3uqPTs8B3XggynoRFoJuhgS-MMxZa0JmyKU9ErEWaicRkmY5tjhFLnmnUcJrAIceHmlKpBYijNd8mq27q7C6hcB-YHBwg5wpeek2hYmuMYtoAEMM63AYJax3KzNOSY3eMO7kgVEa1S1C7RLVLmPJrPuW-4uR4b_BhvTESTg6GQ5Sz08eZZCES_8D9xRtkp9qxuTheQq2ENchxvYXSH-7Ze2sd-V1eDC5unm_N05OWliFXGv4a_v4hoQdkbdjpyYvzwZ8fZB2FVIlDP8lq8fBo9wATFXq_tPv_-GP4EQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-21+Suppresses+Anoikis+through+Targeting+PDCD4+and+PTEN+in+Human+Esophageal+Adenocarcinoma&rft.jtitle=Current+medical+science&rft.au=Zhao%2C+Meng-ya&rft.au=Wang%2C+La-mei&rft.au=Liu%2C+Jing&rft.au=Huang%2C+Xing&rft.date=2018-04-01&rft.pub=Huazhong+University+of+Science+and+Technology&rft.issn=2096-5230&rft.eissn=2523-899X&rft.volume=38&rft.issue=2&rft.spage=245&rft.epage=251&rft_id=info:doi/10.1007%2Fs11596-018-1872-7&rft.externalDocID=10_1007_s11596_018_1872_7 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg |